Newman Ferrara LLP Announces Corporate Governance Investigations of Passage Bio, Inc. (PASG)

Contacts

Newman Ferrara LLP

Jeffrey M. Norton

[email protected]

1250 Broadway, 27th Fl.

New York, NY 10001

(212) 619-5400

Newman Ferrara LLP announced today that the firm is conducting investigations on behalf of shareholders of Passage Bio, Inc. (NASDAQ: PASG) (“Passage” or the “Company”). The investigations concern whether certain of the Passage’s officers and directors breached their fiduciary duties to shareholders, by, among other things: (i) engaging in self-dealing; (ii) affirmatively approving transactions that harmed the Company; and (iii) failing to provide sufficient oversight of the Company’s business practices.

Current stockholders of Passage that seek more information on this matter are invited to contact Newman Ferrara attorneys Jeffrey Norton ([email protected]) or Benjamin Baker ([email protected]) to discuss this investigation and their rights.

Newman Ferrara maintains a multifaceted practice based in New York City with attorneys specializing in complex commercial and multi-party litigation, securities fraud and shareholder litigation, consumer protection, civil rights, and real estate. For more information, please visit the firm website at www.nfllp.com.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.